[CIMB] QoQ TTM Result on 30-Jun-2017 [#2]

Announcement Date
28-Aug-2017
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2017
Quarter
30-Jun-2017 [#2]
Profit Trend
QoQ- 5.84%
YoY- 25.45%
View:
Show?
TTM Result
31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 CAGR
Revenue 17,569,310 17,626,496 17,424,125 17,124,723 16,700,434 16,065,255 15,793,694 7.36%
PBT 6,239,280 6,109,985 5,786,260 5,619,659 5,374,613 4,884,144 4,804,651 19.04%
Tax -1,502,843 -1,502,019 -1,393,264 -1,343,153 -1,360,457 -1,251,187 -1,214,510 15.27%
NP 4,736,437 4,607,966 4,392,996 4,276,506 4,014,156 3,632,957 3,590,141 20.30%
-
NP to SH 4,600,791 4,475,175 4,269,331 4,160,282 3,930,644 3,564,190 3,535,544 19.21%
-
Tax Rate 24.09% 24.58% 24.08% 23.90% 25.31% 25.62% 25.28% -
Total Cost 12,832,873 13,018,530 13,031,129 12,848,217 12,686,278 12,432,298 12,203,553 3.41%
-
Net Worth 46,951,557 47,841,687 48,076,044 46,850,748 46,749,209 45,091,606 43,757,727 4.81%
Dividend
31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 CAGR
Div 2,267,214 2,267,214 2,228,534 2,228,534 1,752,516 1,752,516 1,627,885 24.73%
Div Payout % 49.28% 50.66% 52.20% 53.57% 44.59% 49.17% 46.04% -
Equity
31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 CAGR
Net Worth 46,951,557 47,841,687 48,076,044 46,850,748 46,749,209 45,091,606 43,757,727 4.81%
NOSH 9,225,547 9,225,547 9,057,792 9,052,110 8,867,452 8,868,384 8,715,289 3.86%
Ratio Analysis
31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 CAGR
NP Margin 26.96% 26.14% 25.21% 24.97% 24.04% 22.61% 22.73% -
ROE 9.80% 9.35% 8.88% 8.88% 8.41% 7.90% 8.08% -
Per Share
31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 CAGR
RPS 190.44 192.68 192.37 190.37 188.33 182.02 181.22 3.36%
EPS 49.87 48.92 47.13 46.25 44.33 40.38 40.57 14.76%
DPS 24.58 24.78 24.60 24.77 19.76 19.86 18.68 20.09%
NAPS 5.0893 5.2296 5.3077 5.2082 5.272 5.109 5.0208 0.90%
Adjusted Per Share Value based on latest NOSH - 9,052,110
31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 CAGR
RPS 163.76 164.29 162.40 159.61 155.66 149.74 147.21 7.36%
EPS 42.88 41.71 39.79 38.78 36.64 33.22 32.95 19.21%
DPS 21.13 21.13 20.77 20.77 16.33 16.33 15.17 24.74%
NAPS 4.3762 4.4591 4.481 4.3668 4.3573 4.2028 4.0785 4.81%
Price Multiplier on Financial Quarter End Date
31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 CAGR
Date 30/03/18 29/12/17 29/09/17 30/06/17 31/03/17 30/12/16 30/09/16 -
Price 7.19 6.54 6.30 6.58 5.57 4.51 4.71 -
P/RPS 3.78 3.39 3.28 3.46 2.96 2.48 2.60 28.36%
P/EPS 14.42 13.37 13.37 14.23 12.57 11.17 11.61 15.56%
EY 6.94 7.48 7.48 7.03 7.96 8.95 8.61 -13.40%
DY 3.42 3.79 3.91 3.76 3.55 4.40 3.97 -9.47%
P/NAPS 1.41 1.25 1.19 1.26 1.06 0.88 0.94 31.06%
Price Multiplier on Announcement Date
31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 CAGR
Date 30/05/18 28/02/18 28/11/17 28/08/17 24/05/17 28/02/17 16/11/16 -
Price 5.90 7.19 5.93 6.78 6.13 4.97 4.79 -
P/RPS 3.10 3.73 3.08 3.56 3.25 2.73 2.64 11.31%
P/EPS 11.83 14.70 12.58 14.66 13.83 12.31 11.81 0.11%
EY 8.45 6.80 7.95 6.82 7.23 8.13 8.47 -0.15%
DY 4.17 3.45 4.15 3.65 3.22 4.00 3.90 4.56%
P/NAPS 1.16 1.37 1.12 1.30 1.16 0.97 0.95 14.25%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment